MedTrace Logo

Clinical Assessment of Usage of Cleft Margin Flap With Anterior Palatal Closure in Closure of Naso-alveolar Defect.

NCT03922438 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-11-27

No results posted yet for this study

Summary

During primary cleft lip repair in patients who were born with cleft lip and palate, usage of cleft margin flap with anterior palatal closure will be done in an attempt to close the Naso-alveolar fistula (defect) that usually occur and remain in those patients post-operatively.

Conditions

  • Nasoalveolar Fistula (Defect)

Interventions

PROCEDURE

usage of cleft margin flap with anterior palatal closure during primary cleft lip repair.

Under general anesthesia, preparation of lip and palatal flaps will be done and then cleft margin flap which is designed to be inferiorly based will be used with anterior palatal closure in an attempt to decrease the incidence rate of naso-alveolar fistula (defect) that is usually occur and remain in those patients post-operatively.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed G Beheiri, PhD · Faculty of Oral and Dental Medicine- Cairo University

  • Mamdouh A AboulHassan, PhD · Cairo University

  • Khaled A Salah Eldein, PhD · Faculty of Oral and Dental Medicine- Cairo University

  • Sherif A Hassan, PhD · Faculty of Oral and Dental Medicine- Cairo University

  • Dina Y Girgis, B.D.S · Faculty of Oral and Dental Medicine- Cairo University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Months
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03922438 on ClinicalTrials.gov